Stock Comparison
LLY vs MRK
Eli Lilly and Company and Merck & Company Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.04T
$328.21B
P/E (TTM)
39.1
106.5
Forward P/E
32.1
48.4
Price/Sales
13.0
5.0
Price/Book
30.6
7.2
EV/EBITDA
26.0
50.4
Dividend Yield
0.53%
2.48%
Profitability
Net Margin
33.53%
13.62%
Operating Margin
43.92%
27.59%
Return on Equity
102.30%
18.90%
Return on Assets
20.40%
12.60%
Growth (YoY)
Revenue Growth
47.70%
5.10%
Earnings Growth
26.20%
-19.30%
Price & Risk
Beta
0.5
0.2
52-Week High
$1,235.65
$135.57
52-Week Low
$679.67
$76.39
Analyst Target
$1,297.31
$136.65
Compare LLY and MRK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.